ClinicalTrials.Veeva

Menu

Optimization of NIBS for Treatment of Addiction

Case Western Reserve University logo

Case Western Reserve University

Status

Enrolling

Conditions

Opioid-use Disorder
Chronic Pain

Treatments

Device: Active Comparator: Active tDCS + Active TUS
Device: Sham Comparator: Sham tDCS + Sham TUS

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04379115
STUDY20190760

Details and patient eligibility

About

The purpose of this study is to assess the effects of transcranial Direct Current Stimulation (tDCS) applied in conjunction with Transcranial Ultrasound (TUS) for the treatment of addiction in opiate use disorder with chronic pain. The investigators hypothesize that there will be a decrease in drug use and improved psychosocial assessments with active stimulation, when compared to sham stimulation.

Enrollment

126 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Providing informed consent to participate in the study.

  2. 18 to 85 years old.

  3. Having a diagnosis of OUD, in the setting of CP:

    • OUD of more than 6 months duration as defined by Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [64] and a positive urine toxicology screen.
    • or OUD patients who still feel craving or have not received more than 60 mg of methadone/day from the Methadone program.
  4. Lives in the immediate area with no plans to relocate

Exclusion criteria

  1. The subject is pregnant.

  2. Recently started on antiepileptic drug therapy.

  3. History of illegal stimulant use as demonstrated by urine toxicology.

  4. . Ingestion of poppy seeds or herbal teas containing Papaveris Fructus (may cause a positive opiate test for morphine, codeine [66, 67]).

  5. History of neurological disorders involving stroke, brain tumors, or epilepsy as self- reported (note patients will also be evaluated via electroencephalography (EEG) at baseline 1 week prior to stimulation and any patient showing abnormal EEG activity will be removed)).

  6. History of unexplained fainting spells as self-reported.

  7. History of head injury resulting in more than a momentary loss of consciousness as self-reported.

  8. History of brain surgery as self-reported.

  9. Contraindications to tDCS applied in conjunction with TUS:

    • Metal in the head, or
    • Implanted brain medical devices.
  10. Suffering from severe depression (with a score of >30 in the Beck Depression Inventory (BDI), PHQ-9≥10).

  11. Active malignancy.

  12. History of suicidal behavior or suicide attempts.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

126 participants in 2 patient groups

Active (tDCS) + Active TUS
Active Comparator group
Description:
Subjects in the experimental group will undergo 20 minutes of active transcranial direct current stimulation (tDCS) and active transcranial ultrasound (TUS)
Treatment:
Device: Active Comparator: Active tDCS + Active TUS
Sham (tDCS) + Sham TUS
Sham Comparator group
Description:
Subjects in the sham group will undergo 20 minutes of sham transcranial direct current stimulation (tDCS) and sham transcranial ultrasound (TUS).
Treatment:
Device: Sham Comparator: Sham tDCS + Sham TUS

Trial contacts and locations

2

Loading...

Central trial contact

Megan Miller; Kimberly Bright

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems